Drug intelligence / Profile preview

Bioeffective R

Development stage
Unknown
Lead developer
Solagran
Modality
Small Molecules
Administration
Oral
01

Overview

Bioeffective R is a natural product-based pharmaceutical consisting of high-purity polyprenols (acyclic isoprenoid alcohols) extracted from the green needles of conifer species. It is a registered prescription pharmaceutical in Russia, approved for the treatment of chronic hepatitis and hepatobiliary dysfunction. Polyprenols are naturally occurring analogues and precursors to dolichols, which are essential components of the dolichol phosphate cycle required for the cellular biosynthesis of glycoproteins. By supplementing the dolichol pool, Bioeffective R helps restore cellular membrane integrity and normalize metabolic processes. Clinical research has also indicated potential therapeutic benefits in neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, as well as in the normalization of cholesterol levels and immune responses.

Brand names
RoprenRopren Drops
Other names
polyprenolsconifer needle polyprenolsacyclic isoprenoid alcohols

Beyond the preview

Go deeper on Bioeffective R.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioeffective R.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call